Want to see JP:4936 full AI Analyst Report?
Top Page
AXXZIA, Inc.
(4936)
Select Model
Select Model
Rating:58Neutral
Price Target:
¥336.00
▼(-14.29% Downside)
Action:Reiterated
Date:03/24/26
The score is anchored by stable financial footing (low leverage) and positive, improving free cash flow, but is held back by sharp margin compression in 2025 and clear bearish technical signals (below major moving averages and negative MACD). Dividend yield provides some support, while negative P/E reflects weak current earnings.
Positive Factors
Conservative balance sheet
AXXZIA's very low debt-to-equity (~0.11) and sizable equity base provide durable financial flexibility. This conservatism supports investment in product development, absorbs shocks to margins, and reduces refinancing risk, preserving strategic optionality over multiple quarters.
Negative Factors
Sharp margin compression
The rapid decline in net margin to ~2.6% reflects cost pressures or rising SG&A that materially erode profitability. If below-gross-line costs remain elevated, sustained low net margins will weaken returns on capital and constrain scope for strategic investments or dividends.
Read all positive and negative factors
Positive Factors
Negative Factors
Conservative balance sheet
AXXZIA's very low debt-to-equity (~0.11) and sizable equity base provide durable financial flexibility. This conservatism supports investment in product development, absorbs shocks to margins, and reduces refinancing risk, preserving strategic optionality over multiple quarters.
Read all positive factors
AXXZIA, Inc. (4936) vs. iShares MSCI Japan ETF (EWJ)
Market Cap
¥7.67B
Dividend Yield2.65%
Average Volume (3M)33.33K
Price to Earnings (P/E)44.1
Beta (1Y)1.14
Revenue Growth0.96%
EPS Growth-28.27%
CountryJP
Employees248
SectorConsumer Defensive
Sector Strength42
IndustryHousehold & Personal Products
Share Statistics
EPS (TTM)15.32
Shares Outstanding24,107,000
10 Day Avg. Volume32,930
30 Day Avg. Volume33,333
Financial Highlights & Ratios
PEG Ratio-0.56
Price to Book (P/B)1.38
Price to Sales (P/S)0.77
P/FCF Ratio16.30
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)6.6
Revenue Forecast (FY)¥13.55B
AXXZIA, Inc. Business Overview & Revenue Model
Company Description
AXXZIA Inc. manufactures and sells cosmetics and supplements in Japan. The company offers eyecare, skincare, supplements and drinks, salon care, hair care, hair styling, and beauty device products under the AXXZIA, AGtheory, LisBeau, LisBlanc, The...
AXXZIA, Inc. Financial Statement Overview
Summary
Income Statement
54
Neutral
Balance Sheet
78
Positive
Cash Flow
61
Positive
| Breakdown | Jul 2025 | Jul 2024 | Jul 2023 | Jul 2022 | Jul 2021 |
|---|---|---|---|---|---|
Income Statement | |||||
| Total Revenue | 13.48B | 12.19B | 11.34B | 8.22B | 5.79B |
| Gross Profit | 9.92B | 9.61B | 8.94B | 6.22B | 4.08B |
| EBITDA | 746.64M | 1.29B | 2.06B | 1.84B | 1.40B |
| Net Income | 354.28M | 794.35M | 1.33B | 1.12B | 868.64M |
Balance Sheet | |||||
| Total Assets | 9.62B | 10.54B | 10.70B | 10.05B | 8.27B |
| Cash, Cash Equivalents and Short-Term Investments | 3.99B | 4.93B | 5.79B | 6.39B | 5.94B |
| Total Debt | 860.67M | 975.56M | 632.25M | 654.12M | 213.64M |
| Total Liabilities | 2.04B | 2.01B | 1.80B | 1.66B | 1.07B |
| Stockholders Equity | 7.57B | 8.53B | 8.90B | 8.40B | 7.19B |
Cash Flow | |||||
| Free Cash Flow | 640.22M | 410.77M | 282.75M | 732.86M | 984.56M |
| Operating Cash Flow | 781.65M | 800.36M | 707.85M | 797.69M | 1.06B |
| Investing Cash Flow | -158.54M | -626.66M | -438.69M | -775.36M | -84.51M |
| Financing Cash Flow | -1.48B | -1.55B | -862.75M | 386.43M | 3.96B |
AXXZIA, Inc. Technical Analysis
Negative
392.00
Price Trends
336.90
Negative
349.47
Negative
387.44
Negative
Market Momentum
-5.12
Positive
38.58
Neutral
5.13
Positive
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For JP:4936, the sentiment is Negative. The current price of 392 is above the 20-day moving average (MA) of 330.30, above the 50-day MA of 336.90, and above the 200-day MA of 387.44, indicating a bearish trend. The MACD of -5.12 indicates Positive momentum. The RSI at 38.58 is Neutral, neither overbought nor oversold. The STOCH value of 5.13 is Positive, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for JP:4936.
AXXZIA, Inc. Peers Comparison
UnderperformOutperform
Sector (62)
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
68 Neutral | ¥1.64B | 11.54 | ― | ― | -9.84% | ― | |
67 Neutral | ¥6.45B | 8.50 | ― | 2.38% | 0.66% | 31.88% | |
62 Neutral | $20.33B | 14.63 | -3.31% | 3.23% | 1.93% | -12.26% | |
61 Neutral | ¥5.15B | 24.33 | ― | 1.68% | 4.84% | 57.41% | |
59 Neutral | ¥2.34B | 6.97 | ― | 1.72% | -5.61% | 57.31% | |
58 Neutral | ¥7.67B | 44.07 | ― | 2.65% | 0.96% | -28.27% | |
52 Neutral | ¥5.30B | 21.26 | ― | ― | -18.19% | -65.57% |
* Consumer Defensive Sector Average
JP:4936
AXXZIA, Inc.
328.00
-138.08
-29.63%
JP:4918
Ivy Cosmetics Corporation
291.00
-25.89
-8.17%
JP:4920
Nippon Shikizai, Inc.
1,129.00
101.95
9.93%
JP:4925
HABA Laboratories, Inc.
1,710.00
83.96
5.16%
JP:4926
C'BON COSMETICS Co., Ltd.
1,219.00
110.58
9.98%
JP:4934
Premier Anti-Aging Co., Ltd.
612.00
-328.00
-34.89%
AXXZIA, Inc. Corporate Events
AXXZIA Slashes FY2026 Earnings Outlook on China Slowdown and Rising Costs
Jun 18, 2026
AXXZIA Inc. has sharply revised its consolidated earnings forecast for the fiscal year ending July 31, 2026, cutting expected net sales and now projecting an operating loss instead of a profit, as profit attributable to owners of the parent is als...
AXXZIA Swings to Loss and Cuts Outlook but Maintains Dividend
Jun 18, 2026
AXXZIA reported net sales of ¥9.89 billion for the first three quarters of the fiscal year ending July 2026, a 1.9% decline year on year, and swung to an operating loss of ¥48 million as profits sharply deteriorated. Profit attributable ...
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.